IN FOCUS FEATURE
Understanding Technology Transfer
FROM OUR WEB SITE
NC Research Featured
The Wake Forest Institute for Regenerative Medicine and Tengion are the center of a CBS Evening News story on the future of organ transplants.
From Our Web Site
Yonnie Butler to Direct Statewide Biobusiness Development
Business development consultant Yonnie Butler has joined the North Carolina Biotechnology Center as Business Development Director in the Business and Technology Development unit.
Athenix Signs Collaboration Agreement with Syngenta
Athenix, a 7-year-old Research Triangle Park company whose research was advanced by a $150,000 loan from the North Carolina Biotechnology Center in 2002, has signed a collaboration agreement with Syngenta, which has facilities in Research Triangle Park and Greensboro.
BioMarck Pharmaceuticals Obtains FDA Approval
A Research Triangle Park-based company started with the help of a $15,000 loan from the North Carolina Biotechnology Center in 2002, BioMarck Pharmaceuticals, has won approval from the U.S. Food and Drug Administration to start a Phase Two clinical trial on its experimental respiratory therapy.
E. Norris Tolson Discusses Biofuels
The Biotechnology Center president and chief executive officer discusses how biofuels will impact the state's economy and way of life beyond the gas pump.
Business Insights Deal Struck for Small Bioscience Companies
The North Carolina Biotechnology Center is giving small bioscience companies across the state the opportunity to access Business Insights' market research reports at a significant discount through a trial subscription.
NC State, Partners Get Grant to Make Low-Cost Fuels
North Carolina State University, RTI International and the University of Utah will work together on a three-year, $3.2 million research project funded by the U.S. Department of Energy.
In Focus
Understanding Technology Transfer
The federal government funds most academic life-sciences research in the United States. But prior to 1980, universities were prohibited from patenting inventions arising from federally funded research.
In 1980, however, Congress passed the Bayh-Dole Act, which assigned academic invention ownership rights to their corresponding universities. This gave birth to university technology transfer offices, which now exist in virtually every research-intensive U.S. university.
The Biotechnology Center's Rob Lindberg offers a detailed look into the technology transfer process.
News from Other Sites
Manufacturing Body Parts
"The field of regenerative medicine works under the theory that organs can be grown outside the body. The science could revolutionize organ transplants and make big bucks." The news segment focuses on the Wake Forest University Institute for Regenerative Medicine in Winston-Salem and Tengion, which has a research office, a development laboratory and a pilot manufacturing facility in Winston-Salem.
From CBS News
Four Triangle Companies Get Cash Infusion
"Venture capital firm Hatteras Venture Partners agreed to invest $7.5 million in four Triangle companies in the past 12 months."
From the (Raleigh) News and Observer
Biotechnology Center Wants to Grow Headquarters
"The state-funded Biotechnology Center has hired the Charlotte office of architecture firm Perkins and Will to firm up designs for a structure of more than 24,000 square feet adjoining the existing building."
From the Triangle Business Journal
Etrials Founder Starts Drug-Testing Venture
"John Cline's new company, Clinical Trials of the Americas, plans to seek contracts from drug companies and others to conduct clinical trials — tests involving humans — of experimental drugs, according to documents filed with the Securities and Exchange Commission."
From the (Raleigh) News and Observer
GlaxoSmithKline Agrees to $425M Drug Deal
"The deal gives GSK the worldwide rights to develop, make and sell experimental compounds from San Diego company Amira Pharmaceuticals. One of those compounds, an experimental asthma treatment known as AM103, already has shown promise in early human trials."
From the Triangle Business Journal
Community Watch
- J. Donald deBethizy, president and chief executive officer of Targacept (Winston-Salem), will present at the 10th Annual BIO CEO and Investor Conference at the Waldorf-Astoria Hotel in New York. He will speak Feb. 11 and Feb. 13. Icagen officials will also present at the conference. More.
- The Institute for Emerging Issues at North Carolina State University has appointed Central Carolina Community College instructor Johnny Shull to its GlaxoSmithKline Faculty Fellowship Program for 2008. Shull is the lead instructor in the Department of Business and Economics at the college's Harnett County campus. More.
- AlphaVax of Research Triangle Park named four people to its Cytomegalovirus Advisory Board: Dr. Mark Schleiss, Dr. David Bernstein, Dr. Robert Pass and Dr. Paul D. Griffiths. Robert Olmsted, AlphaVax's vice president for research, will serve as chairman. More.
- PPD of Wilmington purchased InnoPharm, an independent contract research organization, in Smolensk, Russia. More.
- Salix Pharmaceuticals of Raleigh has appointed Mark Sirgo, Pharm. D., to its board of directors. Sirgo is president and CEO of BioDelivery Sciences, also in Raleigh. More.
- Dr. Marian McCord has joined Entegrion's (Research Triangle Park) research and development team. McCord is an associate professor in the Joint Department of Biomedical Engineering with University of North Carolina — Chapel Hill and North Carolina State University. More.
Please send Community Watch items to Jim Shamp.
Save the Date
Mar. 6
MedTech 2008
(Durham)
March 17
Biotech Forum: How To Build A World Class Company In RTP
(Research Triangle Park)
May 19-20
Biotech 2008
(Winston-Salem)
June 17-20
BIO 2008 Conference
NC Pavilion Sponsorship
(San Diego)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, Feb. 7, 2008. For the latest North Carolina biotechnology industry headlines, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.